Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.380
+0.210 (9.68%)
At close: Feb 6, 2026, 4:00 PM EST
2.253
-0.127 (-5.34%)
After-hours: Feb 6, 2026, 6:58 PM EST
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $5.39 million as of February 6, 2026. Its market cap has increased by 124.69% in one year.
Market Cap
5.39M
Enterprise Value
-915.89K
1-Year Change
124.69%
Ranking
Category
Stock Price
$2.38
Market Cap Chart
Since October 2, 2020, Processa Pharmaceuticals's market cap has decreased from $34.40M to $5.39M, a decrease of -84.32%. That is a compound annual growth rate of -29.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 5.40M | -16.92% |
| Dec 31, 2025 | 6.50M | 124.14% |
| Dec 31, 2024 | 2.90M | -64.63% |
| Dec 29, 2023 | 8.20M | -53.41% |
| Dec 30, 2022 | 17.60M | -77.14% |
| Dec 31, 2021 | 77.00M | 10.47% |
| Dec 31, 2020 | 69.70M | 102.62% |
| Oct 2, 2020 | 34.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MetaVia | 5.55M |
| Ernexa Therapeutics | 5.34M |
| Alaunos Therapeutics | 5.22M |
| Mustang Bio | 5.20M |
| 60 Degrees Pharmaceuticals | 4.96M |
| Acurx Pharmaceuticals | 4.84M |
| Xenetic Biosciences | 4.77M |
| Silexion Therapeutics | 4.72M |